103 related articles for article (PubMed ID: 25224625)
1. A novel EGFP-expressing nude mice with complete loss of lymphocytes and NK cells to study tumor-host interactions.
Gotoh K; Kariya R; Matsuda K; Hattori S; Vaeteewoottacharn K; Okada S
Biosci Trends; 2014 Aug; 8(4):202-5. PubMed ID: 25224625
[TBL] [Abstract][Full Text] [Related]
2. Establishment of nude mice with complete loss of lymphocytes and NK cells and application for in vivo bio-imaging.
Kariya R; Matsuda K; Gotoh K; Vaeteewoottacharn K; Hattori S; Okada S
In Vivo; 2014; 28(5):779-84. PubMed ID: 25189889
[TBL] [Abstract][Full Text] [Related]
3. Incubation and application of transgenic green fluorescent nude mice in visualization studies on glioma tissue remodeling.
Dong J; Dai XL; Lu ZH; Fei XF; Chen H; Zhang QB; Zhao YD; Wang ZM; Wang AD; Lan Q; Huang Q
Chin Med J (Engl); 2012 Dec; 125(24):4349-54. PubMed ID: 23253700
[TBL] [Abstract][Full Text] [Related]
4. Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system.
Shima K; Mizuma M; Hayashi H; Nakagawa K; Okada T; Sakata N; Omura N; Kitamura Y; Motoi F; Rikiyama T; Katayose Y; Egawa S; Ishii N; Horii A; Unno M
J Exp Clin Cancer Res; 2012 Jun; 31(1):55. PubMed ID: 22672897
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
Kojima Y; Honda K; Hamada H; Kobayashi N
J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
[TBL] [Abstract][Full Text] [Related]
6. The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gamma.
Arina A; Murillo O; Hervás-Stubbs S; Azpilikueta A; Dubrot J; Tirapu I; Huarte E; Alfaro C; Pérez-Gracia JL; González-Aseguinolaza G; Sarobe P; Lasarte JJ; Jamieson A; Prieto J; Raulet DH; Melero I
Int J Cancer; 2007 Sep; 121(6):1282-95. PubMed ID: 17520674
[TBL] [Abstract][Full Text] [Related]
7. Novel enhanced GFP-positive congenic inbred strain establishment and application of tumor-bearing nude mouse model.
Lan Q; Chen Y; Dai C; Li S; Fei X; Dong J; Shen Y; Dai X; Lu Z; Liu B; Wang Q; Wang H; Zhou Z; Ji X; Wang Z; Huang Q
Cancer Sci; 2020 Oct; 111(10):3626-3638. PubMed ID: 32589305
[TBL] [Abstract][Full Text] [Related]
8. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma.
Min JK; Kim JM; Li S; Lee JW; Yoon H; Ryu CJ; Jeon SH; Lee JH; Kim JY; Yoon HK; Lee YK; Kim BH; Son YS; Choi HS; Lim NK; Kim DG; Hong HJ
Clin Cancer Res; 2010 Jul; 16(14):3571-80. PubMed ID: 20501614
[TBL] [Abstract][Full Text] [Related]
9. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.
Kim Y; Kim MO; Shin JS; Park SH; Kim SB; Kim J; Park SC; Han CJ; Ryu JK; Yoon YB; Kim YT
Ann Surg Oncol; 2014 Aug; 21(8):2684-98. PubMed ID: 24682719
[TBL] [Abstract][Full Text] [Related]
12.
Jung IH; Kim DH; Yoo DK; Baek SY; Jeong SH; Jung DE; Park SW; Chung YY
In Vivo; 2018; 32(4):771-781. PubMed ID: 29936458
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
14. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
15. Scabraside D Extracted from Holothuria scabra Induces Apoptosis and Inhibits Growth of Human Cholangiocarcinoma Xenografts in Mice.
Assawasuparerk K; Vanichviriyakit R; Chotwiwatthanakun C; Nobsathian S; Rawangchue T; Wittayachumnankul B
Asian Pac J Cancer Prev; 2016; 17(2):511-7. PubMed ID: 26925636
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a human cholangiocarcinoma cell line.
Ma S; Hu L; Huang XH; Cao LQ; Chan KW; Wang Q; Guan XY
Oncol Rep; 2007 Nov; 18(5):1195-200. PubMed ID: 17914572
[TBL] [Abstract][Full Text] [Related]
17. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
18. Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinoma.
Fukuda Y; Asaoka T; Eguchi H; Yokota Y; Kubo M; Kinoshita M; Urakawa S; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Kobayashi S; Hirata M; Wada H; Mori M; Doki Y
Cancer Sci; 2020 Feb; 111(2):323-333. PubMed ID: 31799781
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
Meng F; Yamagiwa Y; Ueno Y; Patel T
J Hepatol; 2006 Jun; 44(6):1055-65. PubMed ID: 16469407
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
